First FDA-Approved Pancrelipase Product May Mark New Era for Providers, Patients
FDA’s recent approval of a reformulated version of Solvay Pharmaceutical Inc.’s delayed-release pancrelipase product, Creon, gives pharmacists who are active in the cystic fibrosis community something newa ‘a pancreatic enzyme product that has passed regulatory muster.
by Raelene
